Human CD8 + T-Cell Populations That Express Natural Killer Receptors

키워드

참고문헌 (80)

1. Lanier LL, "NK cell recognition", Annu Rev Immunol, 23, pp.225~274 (2005)
2. Brubaker SW, "Innate immune pattern recognition : a cell biological perspective", Annu Rev Immunol, 33, pp.257~290 (2015)
3. 나민석, "SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals", Immune Network, 21(1), pp.1~11 (2021), 대한면역학회[DOI]
4. Thiery JP, "Adhesion among neural cells of the chick embryo. II. Purification and characterization of a cell adhesion molecule from neural retina", J Biol Chem, 252, pp.6841~6845 (1977)
5. Nitta T, "Involvement of CD56(NKH-1", Leu-19 antigen)as an adhesion molecule in natural killer-target cell interaction, 1989, pp.170, 1757~1761
6. Cooper MA, "Human natural killer cells : a unique innate immunoregulatory role for the CD56(bright)subset", Blood, 97, pp.3146~3151 (2001)
7. Cooper MA, "The biology of human natural killer-cell subsets", Trends Immunol, 22, pp.633~640 (2001)
8. Parrish-Novak J, "Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function", Nature, 408, pp.57~63 (2000)
9. Deignan T, "Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infection", J Hepatol, 37, pp.101~108 (2002)
10. Doherty DG, "The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns", J Immunol, 163, pp.2314~2321 (1999)
11. Norris S, "Natural T cells in the human liver : cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells", Hum Immunol, 60, pp.20~31 (1999)
12. Chan WK, "Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human blood", J Immunol, 191, pp.1625~1636 (2013)
13. Satoh M, "Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2", J Immunol, 157, pp.3886~3892 (1996)
14. Ye L, "CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes", Hepatology, 49, pp.753~762 (2009)
15. Almehmadi M, "Increased numbers and functional activity of CD56+ T cells in healthy cytomegalovirus positive subjects", Immunology, 142, pp.258~268 (2014)
16. Koh JY, "Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner", J Hepatol, 77, pp.1059~1070 (2022)
17. Hu D, "Identification of cytolytic CD161-CD56+ regulatory CD8 T cells in human peripheral blood", PLoS One, 8, pp.e59545~ (2013)
18. Moretta A, "Receptors for HLA class-I molecules in human natural killer cells", Annu Rev Immunol, 14, pp.619~648 (1996)
19. Campbell KS, "Structure", function of human killer cell immunoglobulin-like receptors : lessons from polymorphisms, evolution, crystal structures and mutations, 2011, pp.132, 315~325
20. Pende D, "Killer Ig-like receptors(KIRs) : Their role in NK cell modulation and developments leading to their clinical exploitation", Front Immunol, 10, pp.1179~ (2019)
21. Ferrini S, "T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function", Eur J Immunol, 24, pp.2294~2298 (1994)
22. Guerra N, "Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL", tumor cell interaction, 2002, pp.100, 2874~2881
23. Bonorino P, "Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C", Hepatology, 46, pp.1375~1386 (2007)
24. van der Veken LT, "Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells", J Immunol, 182, pp.92~101 (2009)
25. Ikeda H, "Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor", Immunity, 6, pp.199~208 (1997)
26. Guerra N, "Killer inhibitory receptor(CD158b)modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas", Blood, 95, pp.2883~2889 (2000)
27. Ugolini S, "Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells", Nat Immunol, 2, pp.430~435 (2001)
28. Gati A, "CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling", Cancer Res, 63, pp.7475~7482 (2003)
29. Anfossi N, "Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells", J Immunol, 173, pp.7223~7229 (2004)
30. Björkström NK, "CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells", Blood, 120, pp.3455~3465 (2012)
31. Pieren DK, "Regulatory KIR+ RA+ T cells accumulate with age and are highly activated during viral respiratory disease", Aging Cell, 20, pp.e13372~ (2021)
32. Sallusto F, "Two subsets of memory T lymphocytes with distinct homing potentials and effector functions", Nature, 401, pp.708~712 (1999)
33. Sallusto F, "Central memory and effector memory T cell subsets : function, generation, and maintenance", Annu Rev Immunol, 22, pp.745~763 (2004)
34. Brenchley JM, "Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells", Blood, 101, pp.2711~2720 (2003)
35. Arlettaz L, "Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacity", Eur J Immunol, 34, pp.3413~3422 (2004)
36. Anfossi N, "Biology of T memory type 1 cells", Immunol Rev, 181, pp.269~278 (2001)
37. Li J, "KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19", Science, 376 (2022)
38. Sullivan LC, "Natural killer cell receptors regulate responses of HLA-E-restricted T cells", Sci Immunol, 6 (2021)
39. Alter G, "Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection", J Virol, 82, pp.9668~9677 (2008)
40. Liao YH, "Increased expression of the natural killer cell inhibitory receptor CD94", NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis, 2006, pp.155, 318~324
41. Campillo JA, "Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients", Clin Cancer Res, 12, pp.4822~4831 (2006)
42. Gimeno L, "KIR+ CD8+ T lymphocytes in cancer immunosurveillance and patient survival : gene expression profiling", Cancers(Basel), 12, pp.2991~ (2020)
43. Mishra S, "CD8+ regulatory T cell-a mystery to be revealed", Front Immunol, 12, pp.708874~ (2021)
44. Vivier E, "Immunoreceptor tyrosine-based inhibition motifs", Immunol Today, 18, pp.286~291 (1997)
45. Brooks AG, "NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor", J Exp Med, 185, pp.795~800 (1997)
46. Braud VM, "HLA-E binds to natural killer cell receptors CD94", NKG2A, B and C, 1998, pp.391, 795~799
47. Houchins JP, "Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C", J Immunol, 158, pp.3603~3609 (1997)
48. Mahapatra S, "High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults", PLoS One, 12, pp.e0181134~ (2017)
49. Bertone S, "Transforming growth factor-β-induced expression of CD94", NKG2A inhibitory receptors in human T lymphocytes, 1999, pp.29, 23~29
50. Arlettaz L, "Activating CD94 : NKG2C and inhibitory CD94 : NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR αβ lymphocytes", Eur J Immunol, 34, pp.3456~3464 (2004)
51. Borst L, "The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment", Clin Cancer Res, 26, pp.5549~5556 (2020)
52. Gunturi A, "The role of TCR stimulation and TGF-β in controlling the expression of CD94", NKG2A receptors on CD8 T cells, 2005, pp.35, 766~775
53. Sheu BC, "Up-regulation of inhibitory natural killer receptors CD94", NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma, 2005, pp.65, 2921~2929
54. Jabri B, "TCR specificity dictates CD94", NKG2A expression by human CTL, 2002, pp.17, 487~499
55. Derre L, "Expression of CD94", NKG2-A on human T lymphocytes is induced by IL-12 : implications for adoptive immunotherapy, 2002, pp.168, 4864~4870
56. Salomé B, "NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer", Cancer Cell, 40, pp.1027~1043 (2022)
57. Creelan BC, "The NKG2A immune checkpoint-a new direction in cancer immunotherapy", Nat Rev Clin Oncol, 16, pp.277~278 (2019)
58. André P, "Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells", Cell, 175, pp.1731~1743 (2018)
59. van Montfoort N, "NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines", Cell, 175, pp.1744~1755 (2018)
60. Herbst RS, "Coast : An open-label, phase II, multidrug platform study of durvalumab alone or in combination with oleclumab or monalizumab in patients with unresectable, stage III non-small-cell lung cancer", J Clin Oncol, 40, pp.3383~3393 (2022)
61. Ducoin K, "Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer", OncoImmunology, 11, pp.2046931~ (2022)
62. Gangaev A, "Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features", Nat Commun, 12, pp.2593~ (2021)
63. Jacomet F, "Evidence for eomesodermin-expressing innate-like CD8+ KIR", NKG2A+ T cells in human adults and cord blood samples, 2015, pp.45, 1926~1933
64. White JT, "Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner", Nat Commun, 7, pp.11291~ (2016)
65. Valés-Gómez M, "Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94", NKG2-A and the activating receptor CD94, EMBO J, pp.1999, 18[DOI]
66. Lanier LL, "Association of DAP12 with activating CD94", NKG2C NK cell receptors, 1998, pp.8, 693~701
67. Sottile R, "Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity", Sci Immunol, 6 (2021)
68. Ishiyama K, "Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients", Proc Natl Acad Sci U S A, 119 (2022)
69. Morel E, "CD94", NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis, 2010, pp.125, 703~710
70. Meresse B, "Reprogramming of CTLs into natural killer-like cells in celiac disease", J Exp Med, 203, pp.1343~1355 (2006)
71. Gumá M, "The CD94", NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells, 2005, pp.35, 2071~2080
72. Balin SJ, "Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria", Sci Immunol, 3 (2018)
73. Grant EJ, "The unconventional role of HLA-E : the road less traveled", Mol Immunol, 120, pp.101~112 (2020)
74. Joosten SA, "Characteristics of HLA-E restricted T-cell responses and their role in infectious diseases", J Immunol Res, 2016, pp.2695396~ (2016)
75. Hammer Q, "Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells", Nat Immunol, 19, pp.453~463 (2018)
76. Kovalenko EI, "Surface NKH2C identifies differentiated αβT-cell clones expanded in peripheral blood", Front Immunol, 11, pp.613882~ (2021)
77. Jouand N, "HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition", PLoS Pathog, 14, pp.e1007041~ (2018)
78. Voogd L, "Antigen presentation by MHC-E : a putative target for vaccination?", Trends Immunol, 43, pp.355~365 (2022)
79. Joosten SA, "Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity", PLoS Pathog, 6, pp.e1000782~ (2010)
80. Jiang H, "HLA-E-restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes", J Clin Invest, 120, pp.3641~3650 (2010)

관련 논문AI추천